March 28 — 30, 2026 NEW ORLEANS, LA

Booth #1712

2 Abstracts

ACC 2026

Tempus is a technology company leading the adoption of Al to help providers close care gaps for patients who may have undiagnosed or undertreated cardiovascular disease. We are pleased to share our latest scientific and clinical research findings during the American College of Cardiology 75th Annual Scientific Session & Expo 2026.

Schedule a meeting with us
Abstracts
March 29, 2026
Time
9:30 – 10:30am CT

Retrospective Analysis of the Tempus ECG-AF Algorithm for Predicting New-Onset Atrial Fibrillation in a Large Health System.

Authors
Dr. An Bui (BSMH), Lindsey P. Guirgues (Director of Research Administration, BSMH), Mary Beth Stonich (Heart and Vascular Service Line Coordinator, BSMH), Jill Sunshine (Director of Cardiovascular Services, St. Francis Medical Center), Dr. Miguel Sotelo (Senior Machine Learning Scientist, Tempus), Dr. Linyuan Jing (Senior Staff Machine Learning Scientist, Tempus), Chris Rogers (Senior Director of Strategic Provider Solutions, Tempus), Dr. Paul Nona (Cardiology, Tempus), Dr. Chris Haggerty (VP of Cardiology Research, Tempus), Dr. John Pfeifer (VP of Clinical Cardiology, Tempus), Dr. Brandon Fornwalt (SVP of Cardiology, Tempus), Dr. Brody Wehman (BSMH)

Oral Presentation
March 29, 2026
live session
Time
1:15 – 1:45pm CT

Location
Innovation Stage
Presenters
Dr. Wayne B. Batchelor, Dr. Brian R. Lindman

On ALERT: Using Al-Powered EHR Alerts to Fast Track Evidence Based Care for VHD.

ALERT is the largest known multicenter, cluster-randomized trial to date evaluating an automated EHR-based notification system designed to address the undertreatment of significant valvular heart disease and accelerate time to treatment.

Read more
live session
Time
1:45 – 2:45pm CT

Location
La Nouvelle B

Session
291
Presenters
Dr. Wayne B. Batchelor, Dr. Brian R. Lindman, Megan Coylewright, V. Antoine Keller, Miguel Sotelo, Dongho Shin, Chris Rogers, Graeme Hickey, Jamie Williams, Myra Fan, Sreekanth Vemulapalli

Late Breaking Clinical Trial: Automated Notifications To Improve Referral And Treatment Of Severe Aortic Stenosis And Mitral Regurgitation: Outcomes From The Randomized Alert Trial (Featured Clinical Research IV)

Schedule a meeting with us

We'll be in touch shortly.